laboratorybas
epidemiolog
studi
assess
preval
rsv
respiratori
virus
sampl
collect
first
surveil
year
clinic
trial
wwwclinicaltrialsgov
phase
iii
random
control
studi
evalu
rel
efficaci
trival
splitvirion
influenza
vaccin
compar
unadjuv
vaccin
influenza
season
adult
age
year
older
studi
conduct
contin
northern
hemispher
america
canada
mexico
us
europ
belgium
czech
republ
estonia
franc
germani
norway
poland
romania
see
tabl
footnot
russia
netherland
uk
east
asia
taiwan
studi
particip
communitybas
live
retir
home
allow
mix
commun
bedridden
elderli
individu
elig
inform
consent
given
particip
sampl
us
subject
includ
present
studi
ethic
approv
addit
virolog
studi
would
requir
leav
studi
popul
subject
activ
surveil
undertaken
novemb
april
compris
weekli
biweekli
telephon
contact
home
visit
particip
instruct
report
ili
nose
throat
swab
collect
subject
develop
ili
surveil
period
ili
defin
simultan
occurr
least
respiratori
symptom
nasal
congest
sore
throat
newworsen
cough
dyspnea
sputum
product
wheez
one
system
symptom
headach
fatigu
myalgia
feverish
feel
hot
cold
chill
rigor
fever
oral
temperatur
moderatetosever
ili
clinic
signific
implic
term
complic
associ
healthcar
cost
evalu
etiolog
ili
episod
meet
predefin
sever
criteria
thu
present
studi
sampl
episod
moderatetosever
ili
select
defin
associ
pneumonia
base
sign
symptom
chest
radiograph
demonstr
new
progress
infiltr
hospit
maximum
ie
highest
total
score
achiev
day
daili
influenza
symptom
sever
iss
score
iss
questionnair
assess
sever
symptom
includ
respiratori
cough
sore
throat
nasal
congest
seven
system
headach
feel
feverish
bodi
ach
fatigu
neck
pain
interrupt
sleep
loss
appetit
symptom
use
grade
system
none
mild
moder
sever
valid
influenza
infect
individu
score
system
respiratori
averag
daili
final
score
rang
questionnair
complet
day
nasal
throat
swab
collect
studi
nurs
physician
use
standard
method
within
day
onset
ili
episod
store
nucleic
acid
extract
sampl
store
glaxosmithklin
vaccin
laboratori
sampl
collect
ili
episod
surveil
period
test
sampl
subject
fulfil
criteria
moderatetosever
ili
one
sampl
per
episod
includ
subject
could
includ
ili
episod
meet
sever
criteria
least
symptomfre
day
episod
respiratori
viral
panel
us
ivd
test
luminex
abbott
molecular
ottignieslouvainlaneuv
belgium
qualit
multiplex
rtpcr
use
simultan
detect
identifi
nucleic
acid
differ
pathogen
follow
respiratori
virus
viru
subtyp
genom
amplifi
influenza
subtyp
influenza
b
rsv
subtyp
b
parainfluenza
human
metapneumoviru
rhinovirusenteroviru
test
differenti
adenoviru
coronavirus
sar
describ
elsewher
analyt
sensit
rang
correspond
approxim
genom
equival
primari
object
estim
preval
rsv
nasalthroat
swab
communitybas
elderli
individu
moderatetosever
ili
secondari
object
estim
preval
respiratori
virus
popul
subgroup
defin
pneumonia
occurr
hospit
statu
iss
score
statist
analys
use
sa
version
later
preval
calcul
proport
exact
confid
interv
ci
possibl
associ
preval
baselin
characteristicsclin
symptom
explor
use
logist
regress
signific
level
set
p
glaxosmithklin
biolog
sa
design
studi
collect
analyz
data
interpret
result
wrote
report
author
access
data
final
respons
analysi
interpret
decis
submit
public
rsv
detect
moderatetosever
ili
episod
ci
singl
infect
preval
rsv
detect
episod
pneumonia
episod
hospit
episod
maximum
iss
score
tabl
median
length
hospit
rsv
day
rang
day
vs
median
day
rang
hospit
case
without
rsv
ie
case
anoth
viru
detect
viru
detect
rsv
detect
episod
subject
year
age
ci
episod
year
old
ci
episod
year
old
ci
episod
year
old
ci
subject
without
rsv
similar
age
gender
distribut
similar
proport
pneumonia
episod
mean
iss
score
data
shown
hospit
occur
rsv
posit
episod
rsv
neg
episod
exclud
unknown
hospit
statu
signific
associ
hospit
statu
rsv
detect
fisher
exact
p
rsv
detect
among
moderatetosever
ili
case
russian
feder
sever
countri
fewer
moderatetosever
ili
case
estonia
n
taiwan
n
unit
kingdom
n
tabl
rsv
preval
individu
countri
rang
mexico
czech
republ
highest
preval
observ
czech
republ
norway
germani
signific
associ
countri
rsv
detect
p
rsv
subtyp
b
detect
although
number
subtyp
countri
small
identifi
trend
tabl
viru
includ
rsv
influenza
viru
detect
moderatetosever
ili
episod
highest
preval
respiratori
virus
observ
czech
republ
wherea
lowest
taiwan
tabl
detect
rate
individu
virus
differ
countri
display
pattern
rsv
supplementari
tabl
frequent
report
respiratori
virus
influenza
posit
sampl
rhinovirusenteroviru
posit
sampl
rsv
posit
sampl
coronaviru
human
metapneumoviru
posit
sampl
tabl
multipl
viral
infect
detect
ili
episod
influenza
andor
b
andor
rhinovirusenteroviru
implic
coinfect
tabl
nonrsv
virus
detect
pneumonia
episod
influenza
human
metapneumoviru
rhinovirusenteroviru
tabl
nonrsv
virus
detect
hospit
case
tabl
hospit
among
rsvposit
moderatetosever
ili
episod
common
hospit
among
episod
posit
viru
common
compar
influenza
respect
median
durat
ili
episod
day
clear
pattern
seen
term
episod
durat
accord
viru
type
although
number
small
data
shown
frequenc
individu
respiratori
symptom
subject
singl
infect
preval
viru
type
show
strike
pattern
symptom
accord
viru
type
tabl
fever
frequent
influenza
infect
least
frequent
infect
due
rhinovirusenteroviru
dyspnea
wheez
frequent
rsv
infect
respect
cough
present
viru
type
exploratori
univari
analysi
show
associ
rsv
detect
age
smoke
statu
gender
random
group
adjuv
vs
nonadjuv
trival
influenza
vaccin
primari
studi
factor
found
associ
rsv
detect
among
moderatetosever
ili
episod
highlevel
care
defin
tabl
odd
ratio
ci
p
congest
heart
failur
ci
p
cardiopulmonari
diseas
ci
p
noninflammatori
cerebrovascularneurolog
disord
ci
p
factor
howev
independ
associ
rsv
detect
independ
predictor
rsv
detect
determin
multivari
analysi
use
multiplex
rtpcr
detect
viral
etiolog
moderatetosever
ili
elderli
influenzavaccin
communitydwel
elderli
adult
winter
season
novemb
april
larg
intern
studi
virus
detect
moderatetosever
ili
episod
approxim
onethird
influenza
rsv
rhinovirusenteroviru
coronaviru
human
metapneumoviru
also
import
pathogen
age
group
rsv
detect
sampl
moderatetosever
ili
episod
rsvposit
like
result
hospit
viral
respiratori
infect
howev
influenza
vaccin
may
attenu
sever
influenza
studi
popul
viru
detect
rate
studi
higher
report
number
previou
studi
least
partial
explain
use
sensit
multiplex
rtpcr
detect
differ
virus
subtyp
howev
import
recogn
multiplex
rtpcr
may
differ
analyt
sensit
differ
virus
affect
diagnost
yield
addit
viral
load
may
vari
specif
viral
infect
rsv
viral
load
typic
low
upper
airway
adult
anoth
factor
may
explain
variabl
viru
detect
rate
literatur
clinic
definit
use
trigger
swab
collect
laboratori
test
current
univers
accept
definit
ili
moderatetosever
ili
particular
elderli
popul
clinic
present
may
atyp
attempt
defin
moderatetosever
ili
use
object
subject
criteria
felt
relev
respiratori
ill
rather
minor
cold
fever
occur
less
commonli
elderli
definit
ili
requir
presenc
fever
import
differ
studi
use
ili
definit
evalu
noninfluenza
virus
inclus
fever
obligatori
part
ili
case
definit
would
exclud
around
case
depend
viru
type
major
subject
moderatetosever
ili
identifi
iss
although
everi
attempt
made
captur
case
proport
swab
miss
episod
pneumonia
hospit
may
mean
subject
present
ili
result
pneumonia
deterior
rapidli
swab
could
collect
time
thu
data
may
miss
part
sever
spectrum
diseas
death
occur
test
cohort
note
per
protocol
swab
taken
ili
occur
subject
present
pneumonia
without
preced
ili
per
protocol
definit
would
swab
taken
observ
effect
countri
rsv
preval
driven
mainli
result
countri
czech
republ
russia
effect
probabl
reflect
season
variabl
studi
period
although
cultur
effect
familyhousehold
structur
could
also
contribut
region
differ
observ
studi
individu
countri
multipl
season
consid
differ
diseas
sever
need
fulli
understand
region
burden
rsv
elderli
one
limit
studi
primari
studi
design
evalu
ili
associ
influenza
infect
caus
respiratori
infect
even
though
definit
ili
broad
studi
physician
may
bias
clinic
assess
decis
whether
take
swab
depend
whether
influenza
activ
commun
potenti
limit
studi
includ
subject
receiv
influenza
vaccin
like
reduc
influenza
infect
rate
abl
distinguish
simpl
viral
infect
combin
viral
bacteri
infect
small
number
rsv
posit
subject
meant
subanalys
pneumonia
hospit
statu
unabl
identifi
meaning
associ
final
hospit
statu
unknown
moderatetosever
ili
episod
identifi
independ
predictor
rsv
detect
howev
anoth
studi
found
rsv
infect
frequent
among
adult
congest
heart
failur
chronic
pulmonari
diseas
elderli
individu
chronic
cardiac
respiratori
diseas
therefor
like
benefit
rsv
prevent
prospect
studi
evalu
etiolog
acut
respiratori
infect
communitybas
elderli
individu
one
prospect
us
studi
conduct
winter
season
rsv
detect
use
rtpcr
annual
elderli
individu
live
commun
ill
prevent
normal
daili
activ
patient
prospect
studi
conduct
communitydwel
elderli
person
unit
kingdom
detect
rsv
antibodi
use
complement
fixat
ill
among
person
follow
winter
season
prospect
studi
brazil
reli
passiv
report
acut
respiratori
infect
communitydwel
elderli
detect
viru
use
rtpcr
sampl
rhinovirusenteroviru
detect
case
human
metapneumoviru
rsv
identifi
studi
rsv
detect
rtpcr
sever
ili
elderli
communitydwel
adult
preval
hospit
patient
patient
pneumonia
iss
score
although
studi
design
determin
incid
rate
evalu
diseas
burden
result
consist
previou
report
suggest
rsv
import
caus
moderatetosever
ili
may
associ
hospit
elderli
result
studi
gener
ili
elderli
moderatetosever
ili
repres
ili
identifi
elig
studi
site
addit
studi
limit
year
evalu
multipl
season
may
accur
reflect
global
rsv
impact
observ
countrytocountri
variabl
rsv
detect
highest
proport
rsvposit
episod
occur
czech
republ
poland
variat
requir
studi
time
understand
implic
find
despit
limit
first
global
studi
knowledg
provid
data
rsv
diseas
elderli
consist
report
north
america
studi
confirm
rsv
import
respiratori
pathogen
older
adult
conclus
assess
rsv
preval
use
multiplex
rtpcr
influenzavaccin
subject
age
year
countri
moderatetosever
ili
show
rsv
implic
respiratori
ill
studi
illustr
import
rsv
respiratori
virus
caus
seriou
respiratori
ill
affect
older
adult
around
globe
thu
addit
influenza
prevent
prevent
viral
infect
rsv
could
decreas
sever
ill
elderli
particularli
increas
risk
complic
viral
respiratori
tract
infect
